New York, USA - May 25, 2026 - Creative Biolabs is at the forefront of advancing oncolytic virus therapy development, particularly specializing in oncolytic vaccinia virus enhancement by improving virus replication, tumor selectivity, and efficacy.
New York, USA - May 25, 2026 - Creative Biolabs is at the forefront of advancing oncolytic virus therapy development, particularly specializing in oncolytic vaccinia virus enhancement by improving virus replication, tumor selectivity, and efficacy.